Clinical Trial Supplies 2017 Market Clinical Trial Supplies Market - Global Industry A

Clinical Trial Supplies Market - Global Industry
Analysis, Size, Share, Growth, Trends, and
Forecast 2017 - 2025
Clinical trials are research studies that discover whether a medical treatment,
strategy, or device is effective and safe for humans. There are four stages of clinical
trials: phase Ι, phase ΙΙ, phase ΙΙΙ, and phase ΙV. Identification of pharmacological
actions and tolerability is done in phase I. Phase ΙΙ evaluates drug safety and
efficacy. Phase III involves the evaluation of risk benefit ratio and determination of
dosage interval. Epidemiological data, efficacy, and safety within large diverse
populations and pharmacoeconomics are identified in phase IV.
Clinical trials are complex activities that require synchronization of several different
functions and processes. A pharmaceutical manufacturer’s primary goal in any
clinical study is to optimize clinical trial supplies so that packaged investigational
materials are distributed to patients enrolled in a clinical trial on time. These
activities include, but are not limited to, project management, clinical packaging,
randomization generation, labeling, supply chain logistics, blinding, distribution,
return drug accountability, and destruction.
View Report @
http://www.transparencymarketresearch.com/clinical-trial-supplies-market.html
The clinical trial supplies market can be segmented based on products and services,
therapeutic area, and region. In terms of products and services, the market can be
categorized into manufacturing, packaging, logistics, and distribution. Based on
therapeutic area, the clinical trial supply market can be segmented into oncology,
cardiovascular diseases, neurological diseases, respiratory diseases, orthopedics,
and others. In terms of end-user, the market can be segregated into contract
research organizations, pharmaceutical & biotechnology companies, academic &
research institutes, and others. In terms of region, the market can be divided into
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The global clinical trials supplies market is witnessing strong growth due to the
increasing prevalence of chronic diseases such as cancer, epilepsy, and HIV; rising
demand for outsourcing of drug discovery services, and increased emphasis on
determining toxicity level in early stages of drug discovery. Additionally, increasing
number of life sciences research in various countries and rising government funding
for the development of new drugs are likely to propel the clinical trial supplies
market. New entrants are focusing on new technologies and launch of new products